RecruitingNCT06334692
Autoantibodies Against-nephrin in Idiopathic Nephrotic Syndrome
Studying Hereditary steroid-resistant nephrotic syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Principal Investigator
- Giuseppe Remuzzi, MD, M.DIstituto Di Ricerche Farmacologiche Mario Negri
- Intervention
- In-house ELISA, and ELISA kits from "DBA Italy" (Abbexa).(diagnostic_test)
- Enrollment
- 100 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2028
Study locations (1)
- Clinical Research Center for Rare Disease Aldo e Cele Daccò, Ranica, BG, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06334692 on ClinicalTrials.govOther trials for Hereditary steroid-resistant nephrotic syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06635720REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE)The Hospital for Sick Children
- RECRUITINGNCT06162546ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and BiobankChristoph Aufricht
- RECRUITINGPHASE3NCT05183646A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARBDimerix Bioscience Pty Ltd
- RECRUITINGNCT01605266INSIGHT (Insight Into Nephrotic Syndrome)The Hospital for Sick Children
See all trials for Hereditary steroid-resistant nephrotic syndrome →